TRIM19 enhances the chemosensitivity of endometrial cancer by regulating the TBX2/NRF2 axis
Abstract Background The chemoresistance occurrence significantly hinders the clinical treatment of advanced cancers, frequently leading to treatment failure. It was already known that tripartite motif protein 19 (TRIM19) enhances the chemosensitivity of human ovarian cancers. However, it remained un...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-06-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02717-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|